Abiopharma

News list

DENYES NANCY 🟢 acquired 412.5K shares (1 derivative) of aTYR PHARMA INC (ATYR) at $0.71 Transaction Date: Jan 09, 2026 | Filing ID: 009152

Full text

News bot Jan. 9, 2026, 10:41 p.m.
🔍 DENYES NANCY (Executive)

Company: aTYR PHARMA INC (ATYR)

Report Date: 2026-01-09
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 412,500
- Total shares held: 31,555
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-09 | Code: H | shares_owned_after: 31,555.00 | Footnotes: F1
- Acquired 412,500 shares of Employee Stock Options (right to buy) at $0.7127 per share (Derivative)
  Date: 2026-01-09 | Code: A | Expires: 2036-01-09 | equity_swap_involved: false | shares_owned_after: 412,500.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Includes 2,500 shares acquired on May 15, 2025 and 2,500 shares acquired on November 14, 2025 under the Company's 2015 Employee Purchase Plan.
- F2: The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning February 9, 2026, such that this option will be fully exercisable on January 9, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.